Chinese instructions for Glofitamab

I. Indications: Glofitamab (Glofitamab) is used to treat certain types of B cell-associated lymphoma and leukemia.其具体适应症将由医疗专业人员根据患者的病情和治疗需要来确定。

II. Mechanism of action: Gerfituzumab is a bispecific antibody that promotes the immune system's attack on cancer cells by binding to two different antigens, one associated with tumor cells and the other associated with immune system cells. It helps destroy cancer cells by activating the patient's own immune system.

III. Pharmacology: The pharmacological effects of gaffetuzumab include activation of white blood cells, anti-cancer cell toxicity and apoptosis. The pharmacological properties of the drug will vary depending on the condition treated and the individual patient's circumstances.

IV. Dosage and Dosage: The usage and dosage of gaffetuzumab should be strictly followed as recommended by medical professionals. Generally, the medication may be given as an intravenous injection, and the treatment plan may involve multiple courses. Patients should use it as prescribed by their doctor.

V. Side effects: Gefituzumab may cause a series of side effects, including but not limited to fever, nausea, vomiting, fatigue, allergic reactions, hypotension, etc. The severity and incidence of these side effects vary from patient to patient. Patients should communicate with their doctor regularly during treatment and report any discomfort or side effects.

VI. Warnings and Precautions: The use of gaffetuzumab may be accompanied by a number of potential risks and warnings, including specific adverse reactions, allergic reactions, risk of infection and other treatment-related precautions. Patients should read drug labels carefully and discuss possible risks and benefits with their doctor before treatment.

VII. Contraindications: Contraindications to a drug often include specific disease states, allergies, or other medical conditions related to the use of the drug. Patients must provide a detailed medical history to their physician to determine whether contraindications exist.

VIII. Drug interactions: Gerfituzumab may interact with other drugs, including drug metabolizing enzymes and drug transport proteins. Patients should tell their doctors about all medications they are taking to ensure safe combinations.

IX. Medication in special populations: In specific populations (e.g., pregnant women, lactating women, the elderly, children, etc.), the use of gaffetuzumab may require special caution. The doctor will determine an appropriate treatment plan based on the patient's condition.